Incident diabetes in clinical trials of antihypertensive drugs: a network meta-analysis.
about
Pharmacometabolomics reveals racial differences in response to atenolol treatmentMilnacipran versus other antidepressive agents for depressionEscitalopram versus other antidepressive agents for depressionMechanisms for blood pressure lowering and metabolic effects of thiazide and thiazide-like diureticsUse of angiotensin receptor blockers and risk of dementia in a predominantly male population: prospective cohort analysisThe 2009 Canadian Hypertension Education Program recommendations for the management of hypertension: Part 1--blood pressure measurement, diagnosis and assessment of riskThe 2008 Canadian Hypertension Education Program recommendations for the management of hypertension: Part 1 - blood pressure measurement, diagnosis and assessment of risk2013 Korean Society of Hypertension guidelines for the management of hypertension. Part II-treatments of hypertensionThe metabolic vascular syndrome - guide to an individualized treatmentComparative efficacy and acceptability of first-generation and second-generation antidepressants in the acute treatment of major depression: protocol for a network meta-analysisThird-generation beta-adrenoceptor antagonists in the treatment of hypertension and heart failureProgressive effects of valsartan compared with amlodipine in prevention of diabetes according to categories of diabetogenic risk in hypertensive patients: the VALUE trialMetabolic actions of angiotensin II and insulin: a microvascular endothelial balancing actMelatonin Pathway and Atenolol-Related Glucose Dysregulation: Is There a Correlation?Efficacy and Safety of HER2-Targeted Agents for Breast Cancer with HER2-Overexpression: A Network Meta-AnalysisDrugs for the treatment of pediatric type 2 diabetes mellitus and related co-morbidities.Feeling the pressure: (patho) physiological mechanisms of weight gain and weight loss in humans.Comparing angiotensin II receptor blockers on benefits beyond blood pressureAcute insulin resistance in ST-segment elevation myocardial infarction in non-diabetic patients is associated with incomplete myocardial reperfusion and impaired coronary microcirculatory function.Comparative effectiveness of antihypertensive medication for primary prevention of cardiovascular disease: systematic review and multiple treatments meta-analysis.Combined Angiotensin Receptor Modulation in the Management of Cardio-Metabolic DisordersMetabolic effects of an AT1-receptor blockade combined with HCTZ in cardiac risk patients: a non interventional study in primary careAntihypertensive medications: benefits of blood pressure lowering and hazards of metabolic effects.Management of hypertension with fixed dose combinations of candesartan cilexetil and hydrochlorothiazide: patient perspectives and clinical utilityImpact of abdominal obesity on incidence of adverse metabolic effects associated with antihypertensive medications.Myocardial infarction and stroke associated with diuretic based two drug antihypertensive regimens: population based case-control study.Treatment of prehypertension in diabetes and metabolic syndrome: what are the pros?Evaluation of inconsistency in networks of interventionsEpidemiological and economic burden of metabolic syndrome and its consequences in patients with hypertension in Germany, Spain and Italy; a prevalence-based model.Different angiotensin receptor blockers and incidence of diabetes: a nationwide population-based cohort study.Is diabetes mellitus-linked amino acid signature associated with β-blocker-induced impaired fasting glucose?Alteration in fasting glucose after prolonged treatment with a thiazide diuretic.Distinct vascular and metabolic effects of different classes of anti-hypertensive drugs.Treating hypertension while protecting the vulnerable islet in the cardiometabolic syndromeEffects of the dietary approaches to stop hypertension diet alone and in combination with exercise and caloric restriction on insulin sensitivity and lipids.Anti-hypertensive medicines prescribing for medical outpatients in a premier teaching hospital in Nigeria: a probable shift of paradigm.Antihypertensive drugs and glucose metabolismSafety of statins: an updateA randomised controlled trial for the evaluation of risk for type 2 diabetes in hypertensive patients receiving thiazide diuretics: Diuretics In the Management of Essential hypertension (DIME) study.Angiotensin receptor blocker/diuretic combination preserves insulin responses in obese hypertensives.
P2860
Q21559685-33B648AC-8A19-44E1-8CE9-624434D55D38Q24240125-500599AD-EBF9-4B1C-8FFF-A2B901DC29E0Q24241065-13A1A588-0486-481B-BA7F-F1F2AE53B154Q24608652-06F03AA0-3541-42A6-8A5E-F43C4ED41EF5Q24646726-607A8B82-DE66-4B7F-870C-CBD0917F551FQ24651499-B6B44D81-2F9D-48BA-BBF8-336A029488A2Q24652860-DED234A4-213D-4BB1-8749-A8AC7755B5B8Q26764784-6D193AC3-402C-41CD-B81F-48CDADBF0455Q26767142-8FB90F73-2E13-4E75-A30C-863CD884C1F7Q26779632-392322FE-03C7-44B6-9B79-C32D79624538Q26822825-3E4FC50D-4F0B-4EB8-8F04-555826AB1BC6Q28286410-E88B4F43-FFCD-4634-82D0-87633027C23EQ28390079-098026E8-89F3-4F8C-9867-6E4D54C1CB43Q28397447-32D0CE7B-DC86-4083-8808-63BD4FE826E5Q28547354-CDCF696A-E2CB-4053-A0DF-91E8911EFF48Q30241716-AA8477A6-407A-4640-9437-997A3FA060C4Q30244320-E6C35AD5-0083-4E96-89A3-BB7876632876Q30360678-2DB6816D-C169-4E65-8D42-1F482A7E85C9Q30425798-5BD4B021-117B-429C-A114-89D10AEA5CC3Q30514101-2BF6D39D-3CDC-4C34-8A48-461DD6B44082Q33166521-0E37482A-2459-4853-87BD-D29F78FAEAAFQ33383626-08F14DD3-8A46-48FB-9354-19F5EAB77B2AQ33561456-96DA2731-5E3E-4825-8EBA-13EDA1A9AD43Q33571219-92331DE6-A38F-4CE6-8342-18BA824C70E6Q33609093-8EC9487D-0CD3-4300-87A5-54EF5113B005Q33609742-573BCC86-DB85-42B3-B54D-E6DCF3539144Q33610853-D25E8419-2785-4403-B4E2-A98AE83EB98FQ33620679-304F29D0-5097-4CBD-9AA5-ED70D299BAA9Q33682776-75DA452C-F805-473E-A365-4A297F1A435FQ33689466-49062038-1671-4ED8-9193-352D7B62DC22Q33731708-DFCA9170-813E-4BAA-8699-B629288080D8Q33818595-57691AD4-A3CD-41D5-B49D-4BDDFF164476Q33821236-D47C8C72-A198-408C-8EBE-E95FD27BF3CDQ33840829-CDE19E4D-EA5A-49AC-9BBF-9F08303CBD9EQ33870283-E1AAEC2C-9C6C-4155-B7DD-A1DFCD11FA4AQ33911061-19CD7286-D97C-4743-B6EA-1E98255E9781Q33948469-E159E6F9-ECB8-4214-B1FE-5D3E8264AB8BQ33949312-965721BB-AE0D-4074-A68E-4F6498ED54A5Q33996330-21793773-EDAA-4422-B6C3-EA3C84095406Q34012331-2B33FB46-D325-4F75-B7B2-75D6E7339394
P2860
Incident diabetes in clinical trials of antihypertensive drugs: a network meta-analysis.
description
2007 nî lūn-bûn
@nan
2007 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Incident diabetes in clinical trials of antihypertensive drugs: a network meta-analysis.
@ast
Incident diabetes in clinical trials of antihypertensive drugs: a network meta-analysis.
@en
Incident diabetes in clinical trials of antihypertensive drugs: a network meta-analysis.
@nl
type
label
Incident diabetes in clinical trials of antihypertensive drugs: a network meta-analysis.
@ast
Incident diabetes in clinical trials of antihypertensive drugs: a network meta-analysis.
@en
Incident diabetes in clinical trials of antihypertensive drugs: a network meta-analysis.
@nl
prefLabel
Incident diabetes in clinical trials of antihypertensive drugs: a network meta-analysis.
@ast
Incident diabetes in clinical trials of antihypertensive drugs: a network meta-analysis.
@en
Incident diabetes in clinical trials of antihypertensive drugs: a network meta-analysis.
@nl
P1433
P1476
Incident diabetes in clinical trials of antihypertensive drugs: a network meta-analysis.
@en
P2093
Peter M Meyer
William J Elliott
P304
P356
10.1016/S0140-6736(07)60108-1
P407
P577
2007-01-01T00:00:00Z